Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
, at CEFR level C1 (in compliance with Flanders’ statutory language regulations ). You are able to carry out your work and achieve your objectives with a high degree of independence. You are motivated to work
-
the application process. You will follow up innovations in research of inflammatory diseases, cell death and barrier dysfunction. You develop — or already possess — a strong understanding of the objectives
-
://www.uantwerpen.be/en/research-groups/celw/ ) with the goal to investigate the synergic effect of hyperthermal treatment and conventional anticancer therapy and discover potential biomarkers that can predict
-
of hyperthermal treatment and conventional anticancer therapy and discover potential biomarkers that can predict sensitivity to heat treatment. You will publish the scientific findings in peer-reviewed
-
to define research objectives. Passionate about science, critically-thinking, self-motivated, flexible, and enjoys working in a team Desirable but not required: Programming experience, preferably in
-
%) appointment as a teacher for a period of 1 January 2026 until 14 September 2028 (renewable after positive evaluation and in line with the faculty's strategic objectives). Your gross monthly salary is calculated
-
for resource allocation and multi-objective trade-offs. Background knowledge in mobile and satellite networks, network programmability, and/or NTN architectures is highly appreciated, since these are the target
-
proactive decision-making. Good understanding of mathematical optimization techniques for resource allocation and multi-objective trade-offs. Background knowledge in mobile and satellite networks, network
-
for commuting. The planned start date is 1 February 2026 or as soon as possible after that date. You will do most of your work at Campus Groenenborger in a dynamic and stimulating working environment. Find out
-
. The project begins with bladder cancer detection from urine-derived DNA and expands towards a broader set of urologic and related cancers, ultimately supporting precision diagnostics from urine to clinic